Teva Pharmaceutical Industries Limited (TEVA) stock analysis
In our weekly check, Teva Pharmaceutical Industries Limited is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 3.
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Israel, listed on NYSE as TEVA.
What our checks show for TEVA
Red flags
- Net debt is 6.3x a year of EBITDA (debt/equity 2.13). That limits room in a downturn and raises refinancing risk.
- The net margin is only 2.9%: little room if costs rise.
- The stock has fallen as much as 91% from a peak. Would you have held through that?
Warning signs
- Operating profit covers interest only 2.6 times: a weak year could make the payments hard.
- Analysts expect only about 2.4% a year of growth in revenue.
- Revenue grew only 4.9% a year over the last 3 years.
- Earnings per share fell 41.1% a year over the last 3 years.
- The stock is still below its previous peak.
- Return on capital (ROCE) is only 7.4%.
Strengths
- The net margin rose by 0.3 points over 5 years, to 2.9%.
- The gross margin is 53.5% and has risen by 5.7 points: pricing power is holding.
- Operating cash flow is 3.5x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 148% a year over the next years.
- Analysts expect the net margin to improve by 20.5 points from today's 2.9%.
- A large company: market value $51.92 billion.
Next earnings report: 2027-01-27
Similar companies
HLN · TAK · ZTS · VTRS · ELAN · ALKS
Questions
What grade does Teva Pharmaceutical Industries Limited (TEVA) have?
In our weekly check, Teva Pharmaceutical Industries Limited is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 3. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of TEVA stock?
This week's biggest flags for Teva Pharmaceutical Industries Limited: High debt, Thin margins, Deep past fall. In total 9 of 23 checks show a warning or a red flag.
What does Teva Pharmaceutical Industries Limited do?
Teva Pharmaceutical Industries Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Israel, listed on NYSE as TEVA.
When does Teva Pharmaceutical Industries Limited report earnings next?
The next earnings report is expected on 2027-01-27. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis